|
[1]
|
January, C., et al. (2014) 2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation: Exec-utive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation, 130, 2071-2104. [Google Scholar] [CrossRef]
|
|
[2]
|
January, C., et al. (2019) 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration with the Society of Thoracic Surgeons. Circulation, 140, e125-e151. [Google Scholar] [CrossRef]
|
|
[3]
|
Glader, E., Sjölander, M., Eriksson, M. and Lundberg, M. (2010) Persistent Use of Secondary Preventive Drugs Declines Rapidly during the First 2 Years after Stroke. Stroke, 41, 397-401. [Google Scholar] [CrossRef]
|
|
[4]
|
Alkhouli, M. and Friedman, P. (2019) Ischemic Stroke Risk in Patients with Nonvalvular Atrial Fibrillation: JACC Review Topic of the Week. Journal of the American College of Cardiology, 74, 3050-3065. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Andrade, J., et al. (2018) 2018 Focused Update of the Canadian Cardiovascular Society Guidelines for the Management of Atrial Fibrillation. The Canadian Journal of Cardiology, 34, 1371-1392. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Kirchhof, P., et al. (2016) 2016 ESC Guidelines for the Manage-ment of Atrial Fibrillation Developed in Collaboration with EACTS. European Heart Journal, 37, 2893-2962. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Yaghi, S. & Kamel, H. (2017) Stratifying Stroke Risk in Atrial Fi-brillation: Beyond Clinical Risk Scores. Stroke, 48, 2665-2670. [Google Scholar] [CrossRef]
|
|
[8]
|
Kornej, J., Apostolakis, S., Bollmann, A. and Lip, G. (2013) The Emerging Role of Biomarkers in Atrial Fibrillation. The Canadian Journal of Cardiology, 29, 1181-1193. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Beigel, R., Wunderlich, N., Ho, S., Arsanjani, R. and Siegel, R. (2014) The Left Atrial Appendage: Anatomy, Function, and Noninvasive Evaluation. JACC. Cardiovascular Imaging, 7, 1251-1265. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Shimamoto, K., et al. (2021) Echocardiographic Predictors of Car-dioembolic Stroke Due to Underlying Atrial Fibrillation: Reliable Left Atrial Remodeling Signs in Acute Stroke. Journal of the Neurological Sciences, 427, Article ID: 117514. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Montaner, J., et al. (2008) Etiologic Diagnosis of Ischemic Stroke Subtypes with Plasma Biomarkers. Stroke, 39, 2280- 2287. [Google Scholar] [CrossRef]
|
|
[12]
|
Rosenberg, M., Gottdiener, J., Heckbert, S. and Mukamal, K. (2012) Echocardiographic Diastolic Parameters and Risk of Atrial Fibrillation: The Cardiovascular Health Study. Eu-ropean Heart Journal, 33, 904-912. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Toh, N., et al. (2010) Left Atrial Volume Combined with Atrial Pump Function Identifies Hypertensive Patients with a History of Paroxysmal Atrial Fibrillation. Hypertension (Dallas, Tex.: 1979), 55, 1150-1156. [Google Scholar] [CrossRef]
|
|
[14]
|
Kourliouros, A., Savelieva, I., Kiotsekoglou, A., Jahangiri, M. and Camm, J. (2009) Current Concepts in the Pathogenesis of Atrial Fibrillation. American Heart Journal, 157, 243-252. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Kubota, T., et al. (2009) Evaluation of Left Atrial De-generation for the Prediction of Atrial Fibrillation: Usefulness of Integrated Backscatter Transesophageal Echocardiog-raphy. JACC. Cardiovascular Imaging, 2, 1039-1047. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Wozakowska-Kapłon, B. (2005) Changes in Left Atrial Size in Pa-tients with Persistent Atrial Fibrillation: A Prospective Echocardiographic Study with a 5-Year Follow-Up Period. Inter-national Journal of Cardiology, 101, 47-52. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Andrade, J.G., et al. (2020) The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society Comprehensive Guidelines for the Management of Atrial Fibrillation. Canadian Journal of Cardiology, 36, 1847-1948. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Ruff, C., et al. (2014) Comparison of the Efficacy and Safety of New Oral Anticoagulants with Warfarin in Patients with Atrial Fibrillation: A Meta-Analysis of Randomised Trials. The Lancet (London, England), 383, 955-962. [Google Scholar] [CrossRef]
|